Faulty St. Jude Medical defibrillators were implanted in patients even after a formal recall of the devices last year, according to a warning letter from the U.S. Food and Drug Administration that could pose problems for St. Jude’s new owner.
The Star Tribune reports on the warning letter from the FDA to St. Jude, which indicates regulators aren’t satisfied with the med-tech company’s response to problems at its Sylmar, Calif., plant.
The New York Times also has a story on the FDA report, first issued last week.
